-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

SCI-40 Immune Deregulation in Active Multiple Myeloma

Program: Scientific Program
Session: The Immune System in Multiple Myeloma
Hematology Disease Topics & Pathways:
multiple myeloma, Biological, Diseases, Therapies, Biological Processes, Technology and Procedures, Plasma Cell Disorders, immunotherapy, Lymphoid Malignancies, genomics, Clinically relevant, NGS
Monday, December 7, 2020, 11:25 AM-11:30 AM

Paola Neri, MD

University of Calgary, Calgary, AB, Canada

Disclosures: Neri: Amgen: Consultancy, Honoraria; Janssen: Consultancy, Honoraria; Celgene/BMS: Consultancy, Honoraria.

See more of: The Immune System in Multiple Myeloma
See more of: Scientific Program
<< Previous Presentation | Next Presentation >>